O-2113

From WikiMD's Medical Encyclopedia

O-2113_Structure.svg

O-2113 is a synthetic cannabinoid that has been studied for its potential therapeutic effects. It is a member of the cannabinoid class of compounds, which interact with the endocannabinoid system in the body.

Chemical Structure and Properties[edit]

O-2113 is chemically related to other cannabinoids, such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The specific chemical structure of O-2113 includes a core cannabinoid structure with various functional groups that influence its interaction with cannabinoid receptors.

Pharmacology[edit]

O-2113 primarily interacts with the CB1 and CB2 receptors in the endocannabinoid system. These receptors are part of the G protein-coupled receptor family and are involved in various physiological processes, including pain sensation, mood regulation, and immune response.

CB1 Receptor[edit]

The CB1 receptor is predominantly found in the central nervous system, including the brain and spinal cord. Activation of CB1 receptors by cannabinoids like O-2113 can result in psychoactive effects, although the specific effects of O-2113 are still under investigation.

CB2 Receptor[edit]

The CB2 receptor is primarily located in the immune system and peripheral tissues. Activation of CB2 receptors is associated with anti-inflammatory and immunomodulatory effects. O-2113's interaction with CB2 receptors suggests potential therapeutic applications in conditions involving inflammation and immune response.

Therapeutic Potential[edit]

Research on O-2113 has explored its potential in various medical conditions. Some studies suggest that it may have analgesic (pain-relieving) properties, making it a candidate for the treatment of chronic pain conditions. Additionally, its interaction with the CB2 receptor indicates potential benefits in inflammatory diseases and immune disorders.

Safety and Side Effects[edit]

As with other synthetic cannabinoids, the safety profile of O-2113 is an important consideration. Potential side effects may include dizziness, dry mouth, and changes in appetite. Long-term safety data is limited, and further research is needed to fully understand the risks associated with its use.

Legal Status[edit]

The legal status of O-2113 varies by jurisdiction. In some regions, synthetic cannabinoids are regulated under controlled substances laws, while in others, they may be available for research purposes only.

See Also[edit]

References[edit]


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!



Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?

Get started with evidence based, physician-supervised

affordable GLP-1 weight loss injections

Now available in New York City and Philadelphia:

✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends

Learn more:

Start your transformation today with W8MD weight loss centers.

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.